nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—systemic lupus erythematosus	0.231	1	CbGaD
Enzalutamide—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0292	0.0479	CbGbCtD
Enzalutamide—CYP3A5—Dapsone—systemic lupus erythematosus	0.0271	0.0444	CbGbCtD
Enzalutamide—CYP2C8—Dapsone—systemic lupus erythematosus	0.026	0.0427	CbGbCtD
Enzalutamide—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0255	0.0418	CbGbCtD
Enzalutamide—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0235	0.0385	CbGbCtD
Enzalutamide—ALB—Prednisone—systemic lupus erythematosus	0.0233	0.0383	CbGbCtD
Enzalutamide—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0226	0.037	CbGbCtD
Enzalutamide—CYP2C19—Dapsone—systemic lupus erythematosus	0.0218	0.0358	CbGbCtD
Enzalutamide—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0201	0.0331	CbGbCtD
Enzalutamide—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0188	0.0309	CbGbCtD
Enzalutamide—CYP2C9—Dapsone—systemic lupus erythematosus	0.0181	0.0298	CbGbCtD
Enzalutamide—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0181	0.0297	CbGbCtD
Enzalutamide—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0178	0.0292	CbGbCtD
Enzalutamide—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0171	0.0281	CbGbCtD
Enzalutamide—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0153	0.0251	CbGbCtD
Enzalutamide—CYP2C19—Prednisone—systemic lupus erythematosus	0.0151	0.0248	CbGbCtD
Enzalutamide—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.0149	0.0244	CbGbCtD
Enzalutamide—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0143	0.0236	CbGbCtD
Enzalutamide—ABCB1—Betamethasone—systemic lupus erythematosus	0.0131	0.0215	CbGbCtD
Enzalutamide—ABCB1—Prednisolone—systemic lupus erythematosus	0.0129	0.0212	CbGbCtD
Enzalutamide—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0123	0.0201	CbGbCtD
Enzalutamide—ABCB1—Prednisone—systemic lupus erythematosus	0.0122	0.02	CbGbCtD
Enzalutamide—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0121	0.0198	CbGbCtD
Enzalutamide—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0119	0.0196	CbGbCtD
Enzalutamide—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0117	0.0192	CbGbCtD
Enzalutamide—ALB—Methotrexate—systemic lupus erythematosus	0.0117	0.0192	CbGbCtD
Enzalutamide—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0116	0.019	CbGbCtD
Enzalutamide—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0113	0.0185	CbGbCtD
Enzalutamide—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0109	0.0179	CbGbCtD
Enzalutamide—CYP3A4—Dapsone—systemic lupus erythematosus	0.0105	0.0173	CbGbCtD
Enzalutamide—CYP2C9—cardial valve—systemic lupus erythematosus	0.0101	0.241	CbGeAlD
Enzalutamide—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00944	0.0155	CbGbCtD
Enzalutamide—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00915	0.015	CbGbCtD
Enzalutamide—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00915	0.015	CbGbCtD
Enzalutamide—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00785	0.0129	CbGbCtD
Enzalutamide—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00785	0.0129	CbGbCtD
Enzalutamide—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00774	0.0127	CbGbCtD
Enzalutamide—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00762	0.0125	CbGbCtD
Enzalutamide—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00734	0.0121	CbGbCtD
Enzalutamide—CYP3A4—Prednisone—systemic lupus erythematosus	0.00731	0.012	CbGbCtD
Enzalutamide—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00718	0.0118	CbGbCtD
Enzalutamide—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00693	0.0114	CbGbCtD
Enzalutamide—ABCB1—Methotrexate—systemic lupus erythematosus	0.00612	0.0101	CbGbCtD
Enzalutamide—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00456	0.0075	CbGbCtD
Enzalutamide—CYP2C19—urine—systemic lupus erythematosus	0.00282	0.067	CbGeAlD
Enzalutamide—CYP2C9—urine—systemic lupus erythematosus	0.00218	0.0519	CbGeAlD
Enzalutamide—CYP3A4—urine—systemic lupus erythematosus	0.00166	0.0396	CbGeAlD
Enzalutamide—CYP2D6—urine—systemic lupus erythematosus	0.00164	0.039	CbGeAlD
Enzalutamide—CYP2C19—blood plasma—systemic lupus erythematosus	0.00147	0.035	CbGeAlD
Enzalutamide—CYP2C8—blood plasma—systemic lupus erythematosus	0.00128	0.0305	CbGeAlD
Enzalutamide—CYP3A5—blood plasma—systemic lupus erythematosus	0.00116	0.0275	CbGeAlD
Enzalutamide—CYP2B6—blood plasma—systemic lupus erythematosus	0.00115	0.0274	CbGeAlD
Enzalutamide—CYP2C9—blood plasma—systemic lupus erythematosus	0.00114	0.0271	CbGeAlD
Enzalutamide—CYP3A4—blood plasma—systemic lupus erythematosus	0.000869	0.0207	CbGeAlD
Enzalutamide—CYP2D6—blood plasma—systemic lupus erythematosus	0.000855	0.0203	CbGeAlD
Enzalutamide—AR—connective tissue—systemic lupus erythematosus	0.000845	0.0201	CbGeAlD
Enzalutamide—AR—skin of body—systemic lupus erythematosus	0.000763	0.0181	CbGeAlD
Enzalutamide—AR—kidney—systemic lupus erythematosus	0.000719	0.0171	CbGeAlD
Enzalutamide—AR—cortex of kidney—systemic lupus erythematosus	0.0007	0.0167	CbGeAlD
Enzalutamide—AR—lymphoid tissue—systemic lupus erythematosus	0.000618	0.0147	CbGeAlD
Enzalutamide—ABCB1—blood plasma—systemic lupus erythematosus	0.000615	0.0146	CbGeAlD
Enzalutamide—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000597	0.0142	CbGeAlD
Enzalutamide—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000593	0.0141	CbGeAlD
Enzalutamide—CYP2C8—kidney—systemic lupus erythematosus	0.000581	0.0138	CbGeAlD
Enzalutamide—AR—tendon—systemic lupus erythematosus	0.000581	0.0138	CbGeAlD
Enzalutamide—CYP2B6—skin of body—systemic lupus erythematosus	0.000553	0.0132	CbGeAlD
Enzalutamide—CYP3A5—kidney—systemic lupus erythematosus	0.000525	0.0125	CbGeAlD
Enzalutamide—CYP2B6—kidney—systemic lupus erythematosus	0.000522	0.0124	CbGeAlD
Enzalutamide—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000511	0.0122	CbGeAlD
Enzalutamide—AR—lung—systemic lupus erythematosus	0.000509	0.0121	CbGeAlD
Enzalutamide—AR—nervous system—systemic lupus erythematosus	0.000472	0.0112	CbGeAlD
Enzalutamide—AR—central nervous system—systemic lupus erythematosus	0.000454	0.0108	CbGeAlD
Enzalutamide—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000448	0.0107	CbGeAlD
Enzalutamide—CYP3A4—kidney—systemic lupus erythematosus	0.000394	0.00937	CbGeAlD
Enzalutamide—CYP2D6—kidney—systemic lupus erythematosus	0.000388	0.00922	CbGeAlD
Enzalutamide—CYP3A5—lung—systemic lupus erythematosus	0.000372	0.00884	CbGeAlD
Enzalutamide—CYP2B6—lung—systemic lupus erythematosus	0.00037	0.00879	CbGeAlD
Enzalutamide—CYP2B6—nervous system—systemic lupus erythematosus	0.000342	0.00814	CbGeAlD
Enzalutamide—Rhinitis—Cyclosporine—systemic lupus erythematosus	0.000334	0.00284	CcSEcCtD
Enzalutamide—Hypoaesthesia—Cyclosporine—systemic lupus erythematosus	0.000332	0.00282	CcSEcCtD
Enzalutamide—Pharyngitis—Cyclosporine—systemic lupus erythematosus	0.000331	0.00282	CcSEcCtD
Enzalutamide—Infestation—Hydrocortisone—systemic lupus erythematosus	0.00033	0.00281	CcSEcCtD
Enzalutamide—Infestation NOS—Hydrocortisone—systemic lupus erythematosus	0.00033	0.00281	CcSEcCtD
Enzalutamide—CYP2B6—central nervous system—systemic lupus erythematosus	0.000329	0.00784	CbGeAlD
Enzalutamide—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.000329	0.0028	CcSEcCtD
Enzalutamide—Connective tissue disorder—Cyclosporine—systemic lupus erythematosus	0.000328	0.00279	CcSEcCtD
Enzalutamide—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.000327	0.00278	CcSEcCtD
Enzalutamide—Rhinitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000326	0.00277	CcSEcCtD
Enzalutamide—Hypertension—Leflunomide—systemic lupus erythematosus	0.000325	0.00276	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Triamcinolone—systemic lupus erythematosus	0.000324	0.00276	CcSEcCtD
Enzalutamide—Hypoaesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000324	0.00275	CcSEcCtD
Enzalutamide—Infection—Azathioprine—systemic lupus erythematosus	0.000323	0.00275	CcSEcCtD
Enzalutamide—Pharyngitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000323	0.00275	CcSEcCtD
Enzalutamide—Muscular weakness—Dexamethasone—systemic lupus erythematosus	0.000323	0.00275	CcSEcCtD
Enzalutamide—Muscular weakness—Betamethasone—systemic lupus erythematosus	0.000323	0.00275	CcSEcCtD
Enzalutamide—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000321	0.00273	CcSEcCtD
Enzalutamide—Oedema peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.00032	0.00273	CcSEcCtD
Enzalutamide—Arthralgia—Leflunomide—systemic lupus erythematosus	0.00032	0.00272	CcSEcCtD
Enzalutamide—Connective tissue disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00032	0.00272	CcSEcCtD
Enzalutamide—Anxiety—Leflunomide—systemic lupus erythematosus	0.000319	0.00272	CcSEcCtD
Enzalutamide—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000319	0.00271	CcSEcCtD
Enzalutamide—Sepsis—Methotrexate—systemic lupus erythematosus	0.000318	0.00271	CcSEcCtD
Enzalutamide—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000318	0.00271	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.000318	0.00271	CcSEcCtD
Enzalutamide—ABCB1—nephron tubule—systemic lupus erythematosus	0.000317	0.00755	CbGeAlD
Enzalutamide—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000316	0.00269	CcSEcCtD
Enzalutamide—Infestation—Methylprednisolone—systemic lupus erythematosus	0.00031	0.00264	CcSEcCtD
Enzalutamide—Infestation NOS—Methylprednisolone—systemic lupus erythematosus	0.00031	0.00264	CcSEcCtD
Enzalutamide—Infection—Leflunomide—systemic lupus erythematosus	0.000305	0.00259	CcSEcCtD
Enzalutamide—Angiopathy—Cyclosporine—systemic lupus erythematosus	0.000303	0.00257	CcSEcCtD
Enzalutamide—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000301	0.00256	CcSEcCtD
Enzalutamide—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000301	0.00256	CcSEcCtD
Enzalutamide—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000298	0.00254	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.000296	0.00252	CcSEcCtD
Enzalutamide—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.000295	0.00251	CcSEcCtD
Enzalutamide—Epistaxis—Triamcinolone—systemic lupus erythematosus	0.000293	0.00249	CcSEcCtD
Enzalutamide—Dry skin—Prednisone—systemic lupus erythematosus	0.000292	0.00249	CcSEcCtD
Enzalutamide—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.000292	0.00249	CcSEcCtD
Enzalutamide—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.000291	0.00248	CcSEcCtD
Enzalutamide—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000285	0.00242	CcSEcCtD
Enzalutamide—Muscular weakness—Prednisone—systemic lupus erythematosus	0.000281	0.00239	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000281	0.00239	CcSEcCtD
Enzalutamide—Rhinitis—Triamcinolone—systemic lupus erythematosus	0.00028	0.00238	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.00028	0.00238	CcSEcCtD
Enzalutamide—Rhinitis—Methylprednisolone—systemic lupus erythematosus	0.000279	0.00238	CcSEcCtD
Enzalutamide—ABCB1—kidney—systemic lupus erythematosus	0.000279	0.00663	CbGeAlD
Enzalutamide—Insomnia—Leflunomide—systemic lupus erythematosus	0.000278	0.00236	CcSEcCtD
Enzalutamide—Pharyngitis—Triamcinolone—systemic lupus erythematosus	0.000277	0.00236	CcSEcCtD
Enzalutamide—Paraesthesia—Leflunomide—systemic lupus erythematosus	0.000276	0.00235	CcSEcCtD
Enzalutamide—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000274	0.00233	CcSEcCtD
Enzalutamide—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.000274	0.00233	CcSEcCtD
Enzalutamide—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000272	0.00646	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000265	0.00225	CcSEcCtD
Enzalutamide—Fatigue—Leflunomide—systemic lupus erythematosus	0.000265	0.00225	CcSEcCtD
Enzalutamide—Vertigo—Cyclosporine—systemic lupus erythematosus	0.000261	0.00222	CcSEcCtD
Enzalutamide—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.00026	0.00221	CcSEcCtD
Enzalutamide—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.00026	0.00221	CcSEcCtD
Enzalutamide—CYP3A4—nervous system—systemic lupus erythematosus	0.000258	0.00615	CbGeAlD
Enzalutamide—Neutropenia—Prednisone—systemic lupus erythematosus	0.000258	0.00219	CcSEcCtD
Enzalutamide—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.000254	0.00216	CcSEcCtD
Enzalutamide—CYP2D6—nervous system—systemic lupus erythematosus	0.000254	0.00605	CbGeAlD
Enzalutamide—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000254	0.00216	CcSEcCtD
Enzalutamide—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.000253	0.00215	CcSEcCtD
Enzalutamide—Convulsion—Cyclosporine—systemic lupus erythematosus	0.000252	0.00214	CcSEcCtD
Enzalutamide—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000251	0.00213	CcSEcCtD
Enzalutamide—CYP3A4—central nervous system—systemic lupus erythematosus	0.000249	0.00592	CbGeAlD
Enzalutamide—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.000247	0.0021	CcSEcCtD
Enzalutamide—Anxiety—Cyclosporine—systemic lupus erythematosus	0.000246	0.0021	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000245	0.00209	CcSEcCtD
Enzalutamide—Convulsion—Mycophenolate mofetil—systemic lupus erythematosus	0.000245	0.00209	CcSEcCtD
Enzalutamide—CYP2D6—central nervous system—systemic lupus erythematosus	0.000245	0.00582	CbGeAlD
Enzalutamide—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000245	0.00208	CcSEcCtD
Enzalutamide—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.000244	0.00208	CcSEcCtD
Enzalutamide—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000241	0.00205	CcSEcCtD
Enzalutamide—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.00024	0.00204	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000239	0.00204	CcSEcCtD
Enzalutamide—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000239	0.0057	CbGeAlD
Enzalutamide—Vertigo—Prednisolone—systemic lupus erythematosus	0.000237	0.00202	CcSEcCtD
Enzalutamide—Infection—Cyclosporine—systemic lupus erythematosus	0.000235	0.002	CcSEcCtD
Enzalutamide—Back pain—Triamcinolone—systemic lupus erythematosus	0.000235	0.002	CcSEcCtD
Enzalutamide—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000232	0.00198	CcSEcCtD
Enzalutamide—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000232	0.00197	CcSEcCtD
Enzalutamide—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000232	0.00197	CcSEcCtD
Enzalutamide—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.00023	0.00196	CcSEcCtD
Enzalutamide—Angiopathy—Betamethasone—systemic lupus erythematosus	0.00023	0.00195	CcSEcCtD
Enzalutamide—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.00023	0.00195	CcSEcCtD
Enzalutamide—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.00023	0.00195	CcSEcCtD
Enzalutamide—Convulsion—Prednisolone—systemic lupus erythematosus	0.000229	0.00195	CcSEcCtD
Enzalutamide—Hypertension—Prednisolone—systemic lupus erythematosus	0.000228	0.00194	CcSEcCtD
Enzalutamide—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000227	0.00193	CcSEcCtD
Enzalutamide—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000226	0.00193	CcSEcCtD
Enzalutamide—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000225	0.00191	CcSEcCtD
Enzalutamide—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000224	0.0019	CcSEcCtD
Enzalutamide—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000223	0.0019	CcSEcCtD
Enzalutamide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000222	0.00189	CcSEcCtD
Enzalutamide—Asthenia—Leflunomide—systemic lupus erythematosus	0.00022	0.00187	CcSEcCtD
Enzalutamide—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.000219	0.00186	CcSEcCtD
Enzalutamide—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000218	0.00186	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000218	0.00186	CcSEcCtD
Enzalutamide—ABCB1—bone marrow—systemic lupus erythematosus	0.000218	0.00519	CbGeAlD
Enzalutamide—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000218	0.00185	CcSEcCtD
Enzalutamide—Pruritus—Leflunomide—systemic lupus erythematosus	0.000217	0.00185	CcSEcCtD
Enzalutamide—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000217	0.00184	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000216	0.00184	CcSEcCtD
Enzalutamide—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000215	0.00183	CcSEcCtD
Enzalutamide—Dizziness—Azathioprine—systemic lupus erythematosus	0.000215	0.00183	CcSEcCtD
Enzalutamide—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000214	0.00182	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000214	0.00182	CcSEcCtD
Enzalutamide—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.000213	0.00181	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000211	0.00179	CcSEcCtD
Enzalutamide—Convulsion—Triamcinolone—systemic lupus erythematosus	0.00021	0.00179	CcSEcCtD
Enzalutamide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.00021	0.00179	CcSEcCtD
Enzalutamide—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.00021	0.00179	CcSEcCtD
Enzalutamide—Hypertension—Triamcinolone—systemic lupus erythematosus	0.00021	0.00178	CcSEcCtD
Enzalutamide—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000209	0.00178	CcSEcCtD
Enzalutamide—Infection—Hydrocortisone—systemic lupus erythematosus	0.000209	0.00178	CcSEcCtD
Enzalutamide—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000209	0.00178	CcSEcCtD
Enzalutamide—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000208	0.00177	CcSEcCtD
Enzalutamide—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000207	0.00176	CcSEcCtD
Enzalutamide—Pneumonia—Methotrexate—systemic lupus erythematosus	0.000206	0.00176	CcSEcCtD
Enzalutamide—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000206	0.00176	CcSEcCtD
Enzalutamide—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.000206	0.00175	CcSEcCtD
Enzalutamide—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000205	0.00175	CcSEcCtD
Enzalutamide—Infestation—Methotrexate—systemic lupus erythematosus	0.000205	0.00175	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000205	0.00174	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000205	0.00174	CcSEcCtD
Enzalutamide—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000205	0.00174	CcSEcCtD
Enzalutamide—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000204	0.00174	CcSEcCtD
Enzalutamide—Headache—Azathioprine—systemic lupus erythematosus	0.000204	0.00173	CcSEcCtD
Enzalutamide—Dizziness—Leflunomide—systemic lupus erythematosus	0.000203	0.00173	CcSEcCtD
Enzalutamide—Angiopathy—Prednisone—systemic lupus erythematosus	0.0002	0.0017	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.0002	0.0017	CcSEcCtD
Enzalutamide—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000198	0.00168	CcSEcCtD
Enzalutamide—Vertigo—Betamethasone—systemic lupus erythematosus	0.000198	0.00168	CcSEcCtD
Enzalutamide—ABCB1—lung—systemic lupus erythematosus	0.000198	0.0047	CbGeAlD
Enzalutamide—Infection—Triamcinolone—systemic lupus erythematosus	0.000197	0.00168	CcSEcCtD
Enzalutamide—Infection—Methylprednisolone—systemic lupus erythematosus	0.000197	0.00167	CcSEcCtD
Enzalutamide—Haematuria—Methotrexate—systemic lupus erythematosus	0.000196	0.00167	CcSEcCtD
Enzalutamide—Insomnia—Prednisolone—systemic lupus erythematosus	0.000195	0.00166	CcSEcCtD
Enzalutamide—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000194	0.00165	CcSEcCtD
Enzalutamide—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000194	0.00165	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000194	0.00165	CcSEcCtD
Enzalutamide—Mental disorder—Prednisone—systemic lupus erythematosus	0.000193	0.00164	CcSEcCtD
Enzalutamide—Headache—Leflunomide—systemic lupus erythematosus	0.000192	0.00164	CcSEcCtD
Enzalutamide—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000192	0.00163	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000192	0.00163	CcSEcCtD
Enzalutamide—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000191	0.00162	CcSEcCtD
Enzalutamide—Convulsion—Betamethasone—systemic lupus erythematosus	0.000191	0.00162	CcSEcCtD
Enzalutamide—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00019	0.00162	CcSEcCtD
Enzalutamide—Hypertension—Dexamethasone—systemic lupus erythematosus	0.00019	0.00162	CcSEcCtD
Enzalutamide—Hypertension—Betamethasone—systemic lupus erythematosus	0.00019	0.00162	CcSEcCtD
Enzalutamide—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000189	0.00161	CcSEcCtD
Enzalutamide—Anxiety—Betamethasone—systemic lupus erythematosus	0.000187	0.00159	CcSEcCtD
Enzalutamide—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000187	0.00159	CcSEcCtD
Enzalutamide—ABCB1—nervous system—systemic lupus erythematosus	0.000183	0.00435	CbGeAlD
Enzalutamide—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000183	0.00156	CcSEcCtD
Enzalutamide—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000182	0.00155	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000182	0.00155	CcSEcCtD
Enzalutamide—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000182	0.00154	CcSEcCtD
Enzalutamide—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000181	0.00154	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000181	0.00154	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00018	0.00153	CcSEcCtD
Enzalutamide—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000179	0.00153	CcSEcCtD
Enzalutamide—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000179	0.00152	CcSEcCtD
Enzalutamide—Infection—Dexamethasone—systemic lupus erythematosus	0.000179	0.00152	CcSEcCtD
Enzalutamide—Infection—Betamethasone—systemic lupus erythematosus	0.000179	0.00152	CcSEcCtD
Enzalutamide—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000178	0.00151	CcSEcCtD
Enzalutamide—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000178	0.00151	CcSEcCtD
Enzalutamide—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000176	0.0015	CcSEcCtD
Enzalutamide—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000176	0.0015	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000176	0.0015	CcSEcCtD
Enzalutamide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000176	0.0015	CcSEcCtD
Enzalutamide—ABCB1—central nervous system—systemic lupus erythematosus	0.000176	0.00419	CbGeAlD
Enzalutamide—Vertigo—Prednisone—systemic lupus erythematosus	0.000172	0.00147	CcSEcCtD
Enzalutamide—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000171	0.00145	CcSEcCtD
Enzalutamide—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000171	0.00145	CcSEcCtD
Enzalutamide—Asthenia—Cyclosporine—systemic lupus erythematosus	0.00017	0.00145	CcSEcCtD
Enzalutamide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000168	0.00143	CcSEcCtD
Enzalutamide—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000167	0.00142	CcSEcCtD
Enzalutamide—Convulsion—Prednisone—systemic lupus erythematosus	0.000166	0.00142	CcSEcCtD
Enzalutamide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000166	0.00141	CcSEcCtD
Enzalutamide—Hypertension—Prednisone—systemic lupus erythematosus	0.000166	0.00141	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000164	0.00139	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000164	0.00139	CcSEcCtD
Enzalutamide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000164	0.00139	CcSEcCtD
Enzalutamide—Arthralgia—Prednisone—systemic lupus erythematosus	0.000163	0.00139	CcSEcCtD
Enzalutamide—Anxiety—Prednisone—systemic lupus erythematosus	0.000163	0.00139	CcSEcCtD
Enzalutamide—Insomnia—Betamethasone—systemic lupus erythematosus	0.000163	0.00138	CcSEcCtD
Enzalutamide—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000163	0.00138	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000162	0.00138	CcSEcCtD
Enzalutamide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000162	0.00138	CcSEcCtD
Enzalutamide—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000162	0.00137	CcSEcCtD
Enzalutamide—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000162	0.00137	CcSEcCtD
Enzalutamide—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000161	0.00137	CcSEcCtD
Enzalutamide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000158	0.00135	CcSEcCtD
Enzalutamide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000157	0.00133	CcSEcCtD
Enzalutamide—Infection—Prednisone—systemic lupus erythematosus	0.000156	0.00132	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000155	0.00132	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000155	0.00132	CcSEcCtD
Enzalutamide—Back pain—Methotrexate—systemic lupus erythematosus	0.000155	0.00132	CcSEcCtD
Enzalutamide—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000155	0.00132	CcSEcCtD
Enzalutamide—Fatigue—Betamethasone—systemic lupus erythematosus	0.000155	0.00132	CcSEcCtD
Enzalutamide—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000154	0.00131	CcSEcCtD
Enzalutamide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000153	0.0013	CcSEcCtD
Enzalutamide—Skin disorder—Prednisone—systemic lupus erythematosus	0.000152	0.00129	CcSEcCtD
Enzalutamide—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000151	0.00129	CcSEcCtD
Enzalutamide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000149	0.00127	CcSEcCtD
Enzalutamide—Headache—Cyclosporine—systemic lupus erythematosus	0.000148	0.00126	CcSEcCtD
Enzalutamide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000145	0.00123	CcSEcCtD
Enzalutamide—Vertigo—Methotrexate—systemic lupus erythematosus	0.000144	0.00123	CcSEcCtD
Enzalutamide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000144	0.00123	CcSEcCtD
Enzalutamide—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000144	0.00122	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000143	0.00121	CcSEcCtD
Enzalutamide—Dizziness—Prednisolone—systemic lupus erythematosus	0.000143	0.00121	CcSEcCtD
Enzalutamide—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000142	0.00121	CcSEcCtD
Enzalutamide—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000142	0.00121	CcSEcCtD
Enzalutamide—Insomnia—Prednisone—systemic lupus erythematosus	0.000142	0.00121	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000141	0.0012	CcSEcCtD
Enzalutamide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00014	0.00119	CcSEcCtD
Enzalutamide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00014	0.00119	CcSEcCtD
Enzalutamide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000139	0.00118	CcSEcCtD
Enzalutamide—Convulsion—Methotrexate—systemic lupus erythematosus	0.000139	0.00118	CcSEcCtD
Enzalutamide—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000137	0.00116	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000136	0.00115	CcSEcCtD
Enzalutamide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000135	0.00115	CcSEcCtD
Enzalutamide—Fatigue—Prednisone—systemic lupus erythematosus	0.000135	0.00115	CcSEcCtD
Enzalutamide—Headache—Prednisolone—systemic lupus erythematosus	0.000135	0.00115	CcSEcCtD
Enzalutamide—Headache—Hydrocortisone—systemic lupus erythematosus	0.000132	0.00112	CcSEcCtD
Enzalutamide—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000131	0.00112	CcSEcCtD
Enzalutamide—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000131	0.00111	CcSEcCtD
Enzalutamide—Infection—Methotrexate—systemic lupus erythematosus	0.00013	0.00111	CcSEcCtD
Enzalutamide—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000129	0.0011	CcSEcCtD
Enzalutamide—Asthenia—Betamethasone—systemic lupus erythematosus	0.000129	0.0011	CcSEcCtD
Enzalutamide—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000128	0.00109	CcSEcCtD
Enzalutamide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000128	0.00109	CcSEcCtD
Enzalutamide—Pruritus—Betamethasone—systemic lupus erythematosus	0.000127	0.00108	CcSEcCtD
Enzalutamide—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000127	0.00108	CcSEcCtD
Enzalutamide—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000127	0.00108	CcSEcCtD
Enzalutamide—Headache—Triamcinolone—systemic lupus erythematosus	0.000124	0.00106	CcSEcCtD
Enzalutamide—Headache—Methylprednisolone—systemic lupus erythematosus	0.000124	0.00105	CcSEcCtD
Enzalutamide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000123	0.00105	CcSEcCtD
Enzalutamide—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000123	0.00105	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000119	0.00101	CcSEcCtD
Enzalutamide—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000119	0.00101	CcSEcCtD
Enzalutamide—Dizziness—Betamethasone—systemic lupus erythematosus	0.000119	0.00101	CcSEcCtD
Enzalutamide—Insomnia—Methotrexate—systemic lupus erythematosus	0.000118	0.00101	CcSEcCtD
Enzalutamide—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000118	0.001	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000113	0.000962	CcSEcCtD
Enzalutamide—Fatigue—Methotrexate—systemic lupus erythematosus	0.000113	0.00096	CcSEcCtD
Enzalutamide—Headache—Dexamethasone—systemic lupus erythematosus	0.000113	0.000959	CcSEcCtD
Enzalutamide—Headache—Betamethasone—systemic lupus erythematosus	0.000113	0.000959	CcSEcCtD
Enzalutamide—Asthenia—Prednisone—systemic lupus erythematosus	0.000112	0.000956	CcSEcCtD
Enzalutamide—Pruritus—Prednisone—systemic lupus erythematosus	0.000111	0.000943	CcSEcCtD
Enzalutamide—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000107	0.000912	CcSEcCtD
Enzalutamide—Dizziness—Prednisone—systemic lupus erythematosus	0.000104	0.000881	CcSEcCtD
Enzalutamide—Headache—Prednisone—systemic lupus erythematosus	9.82e-05	0.000835	CcSEcCtD
Enzalutamide—Asthenia—Methotrexate—systemic lupus erythematosus	9.39e-05	0.000799	CcSEcCtD
Enzalutamide—Pruritus—Methotrexate—systemic lupus erythematosus	9.26e-05	0.000788	CcSEcCtD
Enzalutamide—Diarrhoea—Methotrexate—systemic lupus erythematosus	8.96e-05	0.000762	CcSEcCtD
Enzalutamide—Dizziness—Methotrexate—systemic lupus erythematosus	8.66e-05	0.000737	CcSEcCtD
Enzalutamide—Headache—Methotrexate—systemic lupus erythematosus	8.2e-05	0.000698	CcSEcCtD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	4.24e-06	0.00438	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.23e-06	0.00437	CbGpPWpGaD
Enzalutamide—ALB—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	4.21e-06	0.00436	CbGpPWpGaD
Enzalutamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	4.19e-06	0.00433	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	4.15e-06	0.00429	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.09e-06	0.00423	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	4.07e-06	0.00421	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—CRP—systemic lupus erythematosus	4.05e-06	0.00419	CbGpPWpGaD
Enzalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.97e-06	0.0041	CbGpPWpGaD
Enzalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.93e-06	0.00407	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	3.93e-06	0.00406	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	3.92e-06	0.00406	CbGpPWpGaD
Enzalutamide—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.92e-06	0.00405	CbGpPWpGaD
Enzalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.91e-06	0.00405	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	3.88e-06	0.00402	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	3.83e-06	0.00396	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL4—systemic lupus erythematosus	3.82e-06	0.00395	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—F2—systemic lupus erythematosus	3.74e-06	0.00387	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	3.71e-06	0.00384	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	3.7e-06	0.00383	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.66e-06	0.00379	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	3.58e-06	0.0037	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	3.53e-06	0.00365	CbGpPWpGaD
Enzalutamide—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.5e-06	0.00362	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	3.39e-06	0.00351	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	3.37e-06	0.00349	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	3.36e-06	0.00348	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	3.36e-06	0.00347	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.35e-06	0.00347	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—CCL2—systemic lupus erythematosus	3.34e-06	0.00345	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	3.31e-06	0.00343	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—CRP—systemic lupus erythematosus	3.3e-06	0.00341	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	3.27e-06	0.00338	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.27e-06	0.00338	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.23e-06	0.00334	CbGpPWpGaD
Enzalutamide—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.22e-06	0.00333	CbGpPWpGaD
Enzalutamide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.19e-06	0.0033	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	3.15e-06	0.00326	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	3.11e-06	0.00322	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—NAT2—systemic lupus erythematosus	3.05e-06	0.00315	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—F2—systemic lupus erythematosus	3.04e-06	0.00315	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MTA2—systemic lupus erythematosus	3.04e-06	0.00314	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	3.02e-06	0.00313	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	3.02e-06	0.00312	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.01e-06	0.00311	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.98e-06	0.00308	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	2.98e-06	0.00308	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	2.98e-06	0.00308	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.97e-06	0.00307	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	2.93e-06	0.00303	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	2.9e-06	0.003	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	2.84e-06	0.00293	CbGpPWpGaD
Enzalutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.78e-06	0.00287	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	2.77e-06	0.00286	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—CCL2—systemic lupus erythematosus	2.71e-06	0.00281	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	2.69e-06	0.00278	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	2.67e-06	0.00276	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	2.65e-06	0.00274	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	2.63e-06	0.00272	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	2.62e-06	0.00271	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.6e-06	0.00269	CbGpPWpGaD
Enzalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	2.59e-06	0.00268	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	2.58e-06	0.00267	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.48e-06	0.00256	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—RXRA—systemic lupus erythematosus	2.46e-06	0.00254	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	2.45e-06	0.00253	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.42e-06	0.0025	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—RXRA—systemic lupus erythematosus	2.4e-06	0.00249	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	2.4e-06	0.00248	CbGpPWpGaD
Enzalutamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	2.33e-06	0.00241	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.32e-06	0.0024	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IFNG—systemic lupus erythematosus	2.31e-06	0.00239	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.26e-06	0.00234	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	2.21e-06	0.00229	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.16e-06	0.00223	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.1e-06	0.00218	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	2.08e-06	0.00215	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	2.05e-06	0.00212	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	2.05e-06	0.00212	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	2.04e-06	0.00211	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.03e-06	0.0021	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.03e-06	0.0021	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.02e-06	0.00209	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.99e-06	0.00206	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SNRPB—systemic lupus erythematosus	1.99e-06	0.00206	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.99e-06	0.00206	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.97e-06	0.00203	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	1.93e-06	0.002	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.93e-06	0.00199	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	1.9e-06	0.00197	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.88e-06	0.00195	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	1.86e-06	0.00192	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.84e-06	0.0019	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	1.84e-06	0.0019	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	1.84e-06	0.0019	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.83e-06	0.0019	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.78e-06	0.00184	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	1.76e-06	0.00182	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	1.75e-06	0.00181	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	1.75e-06	0.00181	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—F3—systemic lupus erythematosus	1.72e-06	0.00178	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	1.71e-06	0.00177	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	1.69e-06	0.00175	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.69e-06	0.00175	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	1.67e-06	0.00172	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.66e-06	0.00171	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.61e-06	0.00167	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	1.61e-06	0.00167	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.6e-06	0.00166	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.6e-06	0.00165	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—CLU—systemic lupus erythematosus	1.56e-06	0.00161	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	1.56e-06	0.00161	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	1.53e-06	0.00158	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	1.51e-06	0.00156	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	1.49e-06	0.00155	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	1.49e-06	0.00154	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	1.48e-06	0.00153	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.47e-06	0.00152	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	1.42e-06	0.00147	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	1.42e-06	0.00147	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SELE—systemic lupus erythematosus	1.39e-06	0.00144	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—CSK—systemic lupus erythematosus	1.39e-06	0.00144	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.37e-06	0.00142	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	1.37e-06	0.00142	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.37e-06	0.00141	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	1.33e-06	0.00138	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	1.32e-06	0.00137	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.32e-06	0.00136	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	1.31e-06	0.00135	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	1.31e-06	0.00135	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.3e-06	0.00135	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.28e-06	0.00133	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—LYN—systemic lupus erythematosus	1.26e-06	0.0013	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	1.24e-06	0.00128	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.21e-06	0.00126	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	1.21e-06	0.00125	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.19e-06	0.00123	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	1.16e-06	0.0012	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.13e-06	0.00117	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.12e-06	0.00116	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—JUNB—systemic lupus erythematosus	1.12e-06	0.00115	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—RXRA—systemic lupus erythematosus	9.79e-07	0.00101	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	9.72e-07	0.00101	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	9.57e-07	0.00099	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	9.47e-07	0.000979	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—VDR—systemic lupus erythematosus	8.86e-07	0.000917	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	8.28e-07	0.000857	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.99e-07	0.000827	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NR3C1—systemic lupus erythematosus	7.98e-07	0.000825	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.95e-07	0.000822	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	7.85e-07	0.000811	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	7.8e-07	0.000806	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	7.56e-07	0.000782	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NAT2—systemic lupus erythematosus	7.5e-07	0.000776	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—JAK1—systemic lupus erythematosus	7.34e-07	0.000759	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	7.33e-07	0.000758	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	7.24e-07	0.000749	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.14e-07	0.000738	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.89e-07	0.000712	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	6.86e-07	0.000709	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	6.63e-07	0.000685	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.62e-07	0.000685	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.53e-07	0.000675	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.51e-07	0.000673	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	6.35e-07	0.000657	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NAT2—systemic lupus erythematosus	6.31e-07	0.000653	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—PPARG—systemic lupus erythematosus	6.18e-07	0.000639	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	6.08e-07	0.000629	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.99e-07	0.000619	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—F2—systemic lupus erythematosus	5.97e-07	0.000617	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	5.67e-07	0.000586	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.59e-07	0.000578	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	5.53e-07	0.000572	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	5.21e-07	0.000539	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	5.17e-07	0.000535	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.05e-07	0.000522	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.02e-07	0.000519	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NOS3—systemic lupus erythematosus	4.74e-07	0.00049	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.54e-07	0.000469	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.51e-07	0.000466	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	4.21e-07	0.000435	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	4.11e-07	0.000425	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.11e-07	0.000425	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.05e-07	0.000419	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2—systemic lupus erythematosus	4.02e-07	0.000416	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.97e-07	0.000411	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.95e-07	0.000408	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.76e-07	0.000389	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.69e-07	0.000382	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—EP300—systemic lupus erythematosus	3.61e-07	0.000373	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	3.56e-07	0.000368	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.54e-07	0.000367	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—RXRA—systemic lupus erythematosus	3.54e-07	0.000366	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	3.42e-07	0.000353	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.41e-07	0.000353	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.3e-07	0.000342	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.28e-07	0.00034	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.23e-07	0.000334	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	3.18e-07	0.000329	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	3.14e-07	0.000324	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.1e-07	0.000321	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.95e-07	0.000305	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.92e-07	0.000302	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	2.9e-07	0.0003	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.69e-07	0.000278	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	2.66e-07	0.000275	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	2.6e-07	0.000268	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	2.39e-07	0.000247	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.33e-07	0.000241	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	2.28e-07	0.000236	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.25e-07	0.000232	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—systemic lupus erythematosus	2.24e-07	0.000231	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	2.23e-07	0.000231	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	2.09e-07	0.000216	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	2.04e-07	0.000211	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.02e-07	0.000209	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.01e-07	0.000207	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.96e-07	0.000203	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.93e-07	0.0002	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.92e-07	0.000199	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.91e-07	0.000198	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.85e-07	0.000191	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.83e-07	0.000189	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	1.8e-07	0.000187	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.77e-07	0.000183	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.76e-07	0.000182	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.76e-07	0.000182	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	1.74e-07	0.00018	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	1.73e-07	0.000178	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	1.7e-07	0.000176	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.68e-07	0.000174	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.66e-07	0.000172	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.64e-07	0.00017	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.59e-07	0.000164	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	1.58e-07	0.000163	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.57e-07	0.000163	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.54e-07	0.000159	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.47e-07	0.000152	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—EP300—systemic lupus erythematosus	1.46e-07	0.000151	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.45e-07	0.00015	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.44e-07	0.000149	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.31e-07	0.000136	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.28e-07	0.000132	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.21e-07	0.000125	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.21e-07	0.000125	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.2e-07	0.000124	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.08e-07	0.000112	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.04e-07	0.000107	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	9.49e-08	9.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.89e-08	8.16e-05	CbGpPWpGaD
